Literature DB >> 16462577

Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study.

Nicholas G Angelopoulos1, Eugenia Katounda, Grigorios Rombopoulos, Anastasia Goula, Victoria Kaltzidou, Dimitrios Kaltsas, Pappas Ioannis, George Tolis.   

Abstract

Osteoporosis is a common, multifactorial cause of morbidity in patients with beta-thalassemia. The present study was performed to compare bone mineral density (BMD) results in the lumbar spine of thalassemic patients measured by both dual-energy x-ray absorptiometry (DEXA) and quantitative computed tomography (QCT), and to determine their correlations with the markers of bone turnover. BMD was measured in the lumbar spine of 13 regularly transfused patients with beta-thalassemia major by both DEXA and QCT. Blood and urine samples were obtained for the determination of biochemical and hormonal profiles. Both T-scores and Z-scores were higher when measured by QCT (T-score = -0.41 +/- 1.31, Z-score = -0.56 +/- 1.08, mean +/- SD) compared with the values given by DEXA (T-score = -2.57 +/- 0.88, Z-score = -2.32 +/- 1.11, P = 0.0005). In comparison to DEXA, QCT T-scores were more closely correlated with age (r = -0.19 vs. r = -0.70, P = 0.0068). Strong negative correlation was found between QCT values and age (r = -0.67, P = 0.01). In comparison to DEXA T-scores, QCT T-scores were more closely correlated with osteocalcin, urine N-telopeptide cross-links of type I collagen, and deoxypyridinoline, but without statistical significance. DEXA T-scores were better correlated only with urine C-terminal telopeptides of type I collagen, but again without statistical significance. These results imply that the two methods cannot be used interchangeably in assessing BMD in thalassemic patients. However, which one of these two techniques more precisely determines the overall strength of vertebrae in patients with beta-thalassemia remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16462577     DOI: 10.1097/01.mph.0000199587.76055.21

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

Review 1.  Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507

2.  The role of using different reference population in the prevalence of low BMD in the thalassemia patients.

Authors:  Mohammad Reza Mohajeri-Tehrani; Najmeh Darvishian; Faezeh Arab; Sedigheh Salemkar; Fariba Mohseni; Bagher Larijani; Zohreh Hamidi
Journal:  J Diabetes Metab Disord       Date:  2019-11-14

3.  Predictors of bone disease in Egyptian prepubertal children with β-thalassaemia major.

Authors:  Azza A G Tantawy; Eman A El-Bostany; Randa M Matter; Eman A El-Ghoroury; Shadia Ragab
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.